Transaction · 0001615219-26-000004

HANISH ARNOLD C

HANISH ARNOLD C, DIR, reported an open-market or private sale at Salarius Pharmaceuticals, Inc. involving 15.000000 shares for an estimated $9.60. Reported holdings after the transaction were 5000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
SLRXSalarius Pharmaceuticals, Inc.
Filing timeJan 02
Trade dateDec 30, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$0.65
Pre-filing
1mo ago +456.9%1w ago +33.8%1d ago +33.8%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

SLRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
SLRX since 2026-01-02Filed 244 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001615219-26-000004
Common Stock
Transaction date
Dec 30, 2025
Filed Jan 02, 2026, 10:13 PM · 3d delay
Shares
15 sh
$64 per share
Estimated value
-$960
Computed from shares × price
Holdings after
5.00k sh
Indirect · By Arnold C. Hanish Trust
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended

No footnotes recorded.

Original filing · 0001615219-26-000004
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

SLRX